Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Lands GSA Contract, Opens Way for New Gov't Deals; Shares Surge 33 Percent

NEW YORK (GenomeWeb News) — Nanogen can sell its NanoChip 400 microarray and reagents to government departments under a US Government Service Administration contract, the company said today.
 
Nanogen said the GSA schedule vendor contract will allow it to sell the microarray technology and reagents directly to the National Institutes of Health, Veteran’s Administration hospitals, and military hospitals.
 
According to Nanogen, because government agencies have separate budgets for GSA-approved vendors, its government customers will be able to buy its products more expediently using a wider pool of funds.
 
News of the arrangement caused shares in Nanogen to climb 33.33 percent, or $.42, to $1.68 in mid-afternoon trading today.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.